A series of penicillins and cephalosporins containing the substituted 6-vinyl-l,2-dihydro-2-oxo-and 1,4-dihydro-4-oxo-3-pyridinecarboxylic acid side chains has been prepared and compared to piperacillin and cefoperazone. The compounds show good activity when tested in vitro against an array of Gram-negative bacteria.
In vitro activity was also demonstrated against several species of Gram-positive bacteria. Two compounds, 14 and 21, show good in vivo activity when tested against Klebsiella pneacunoniae, Enterobacter cloacae, and two strains of Pseudonnofras aeruginosa.
A large number of penicillins and cephalosporins are currently available for therapy against bacterial infections, and research in this area continues unabated. The goal of our research effort was the synthesis of compounds having a broad spectrum activity against Gram-negative bacteria.
We were particularly interested in combating the more serious infections encountered in hospitals and caused by Klebsiella, Eiiterobacter, and particularly Pseudomonas species. When we began our work the only penicillins showing ant i-Pseudomonas activity were carbenicillin, piperacillinl1) and ticarcillin, all of which showed only moderate in vivo activity against this species. The leading new cephalosporins at that time were cefamandole and cefazolin, both of which had no significant anti-Pseudomonas activity, and cefoperazone2), which showed only moderate in vivo anti-Pseudomonas activity.
Since that time several cephalosporins have been reported to have Pseudomonas activity, the most potent compound among them being ceftazidime3).
Recent reports4-8) from these laboratories have described the excellent broad-spectrum activity against Gram-negative bacteria, especially against Pseudomonas species, conferred on penicillins and cephalosporins by the 1,2-dihydro-2-oxo-6-(substituted)phenyl-3-pyridinecarboxylic acid moiety, 1.
In pursuing this lead, we decided to explore the effect on activity of inserting an ethylene spacer in the 6-position between the pyridone ring and the aryl group leading to compounds of type 2. The effect on activity conferred by the isomeric 4-pyridone derivatives 3 was also explored. The vinyl pyridone side chains were prepared according to Scheme 1.
A detailed description of this synthetic route, together with the physical properties of the vinyl pyridones used in this work has recently been published.9) When the carbonyl compound which was added to the pyridone dianion was a pyridyl ketone (R1, R2 = H), the intermediate tertiary alcohol could not be dehydrated and compounds of type 5 resulted from acid hydrolysis.
Oxidation of the (methylthio)phenyl pyridone derivative with excess hydrogen peroxide gave the corresponding sulfone (side chain for 21). Bromination of the 2-pyridyl pyridone derivative resulted in bromination of the pyridone ring rather than the vinyl grouping to give the 5-bromo derivative (side chain for 25). The pyridones were activated for coupling by preparing the imidazolides with 1,1'-carbonyldiimidazole. These were condensed with the appropriate 3-lactams in N,N-dimethylacetamide. The products were isolated, suspended in water, and the pH adjusted to 6.5 7.5. Freeze-drying gave the ilactam derivatives as the sodium salts.
Antimicrobial Activity
The in vitro antibacterial activities were determined by microtitration dilution10) in Trypticase soy broth with an inoculum of 103 cfu (colony forming units) for Gram-negative bacilli.
The tests for
Staphylococcus and Streptococcus were run using an inoculum of 105 cfu. The minimum inhibitory concentrations (MIC) were determined after 16 18-hour incubation at 37°C on the basis of complete inhibition of visible growth. These results are listed in Tables 1, 2 LDA : Lithium diisopropylamide. Table 1 . In vitro antibacterial activity (MIC, ug/ml). Table 2 . In vitro antibacterial activity (MIC, ttg/ml). a See footnote of Table 1 . Table 3 . In vitro antibacterial activity (MIC, ug/ml). These results are listed in Table 4 .
RI-CH=CH
Results and Discussion Table 1 shows the activities when these side chains are attached to the amino group of amoxicillin.
All the penicillins thus formed show good activity against the broad array of Gram-negative bacteria that we use in our initial screen. Good activity was also demonstrated against the Gram-positive species
Staphylococcus aureus UC-76 and Streptococcus faecalis MGH-2. None were active against S. aureus 518713, a t3-lactamase producing antibiotic resistant strain. Certain of these compounds either matched or bettered the activity of piperacillin1), except for activity versus Enterobacter cloacae and Proteus vulguns.
In the broad area of Gram-negative bacteria, our particular interest was to find compounds active against Pseudomonas species. Several of these compounds, 12, 13, 14, 15, 18, 19 and 21 showed excellent MIC values when tested against three different strains of Pseudomonas aeruginosa.
In Table 2 , the compounds containing the tertiary alcohol in the side chain which could not be dehydrated showed a fall off in activity against all the Gram-negative species, although compound 29 still maintained respectable MIC values. Table 3 contains the results of attaching several of these side chains to cephalosporins. It also contains compounds where the 6-vinyl-l,4-dihydro-4-oxo-3-pyridinecarboxylic acid moiety is appended.
In general the overall activities were somewhat lower than the corresponding penicillins. Compounds 34 and 35 maintained excellent activity against all Pseudomonas strains. Noticeable departures of activity were particularly evident versus Serratia marcescens and Escherichia coli. The penicillinase pro- Table 4 . In vivo activity, PD50 (mg/kg, mice) (total of 2 doses). ducing S. aureus S18713 was susceptible to all the cephalosporins prepared. Table 4 shows the in vivo activity of the penicillin derivatives. When high PD50 values versus P.
aeruginosa UI-18 or LD50 values <2,000 mg/kg dampened our interest in a particular compound, in vivo evaluation versus the other Gram-negative species was not performed. Among the penicillins, compounds 13, 14 and 21 exhibited good in vivo activity against Klebsiella, Enterobacter and two strains of P. aeruginosa. These activities compare quite favorably with 26, a compound described by ISAKA et al.11) and piperacillin (27)1). The LD50 of both 14 and 21 was > 2,000 mg/kg. The tertiary alcohols 28~30 and cephalosporins 31~35 showed disappointing in vivo activity against P. aeruginosa UI-18 and consequently were not tested further. An exception was 34 which had a PD50 vs. Klebsiella pneumoniae MGH-2 of 24 mg/kg and vs. P. aeruginosa UI-18 of 40 mg/kg. The physical constants of the penicillins and cephalosporins that we have prepared are listed in Table 5 . )ethenyl]-3-pyridinecarboxylic acid in 100 ml of DMF was treated with 9.38 g (57.8 mmol; a 40% excess) of 1,1'-carbonyldiimidazole and heated at 60°C for 1 hour. Solution occurred in about 5 minutes, and another solid started to form immediately. The suspension was diluted with a 1 : 3 mixture of CH2Cl2 -Et2O and the product collected. There was obtained 10.44 g (86.5 %) of the product which was used directly in the subsequent coupling step.
Amoxicillin -DMSO Complex 50 g of amoxicillin • 3H2O was added in portions with stirring to 375 ml of DMSO. The mixture was stirred at room temp for 2 hours, then diluted with 75 nil of CH.CI,. After cooling in ice, the product was collected by filtration and washed with CH2Cl2. Analysis showed 3 mol of DMSO and 0.5 mol of H2O for each mol of amoxicillin. The effective formula weight was 609. The reaction mixture was stirred at 0°C for 1 hour, and then at room temp for 2 hours.
Solution occurred in about 40 minutes. The solution was poured into 800 ml of ice water and the pH brought to 2.9 with dilute HCl.
The solid was collected and resuspended twice in cold water. 
